Why we publish what failure costs

Most healthcare compliance vendors sell the same way: pick a scary number, drop it in a hero banner, and hope the buyer is scared enough to book a call. The number is usually unsourced, the context is usually missing, and the buyer can usually tell.

We are publishing a different kind of page. It is called Cost of non-compliance, and it does one thing: it points you to the regulator's own public record.

The regulator already did the work

ONC publishes information-blocking policy and enforcement. CMS publishes interoperability disincentive determinations. HHS OCR publishes every HIPAA settlement, every civil money penalty, and every breach affecting 500 or more individuals. ONC-ACBs publish their certification surveillance findings. State Attorneys General publish their privacy enforcement.

All of it is public. None of it requires a vendor to invent.

The financial penalty is rarely the largest cost. The published narrative is.

What we will not do

  • Name companies in our own voice. The regulator did that work; we cite the regulator.
  • Quote a fine without a direct source link. If we cannot link to the actual notice, we do not use the number.
  • Build an "ROI calculator" with made-up inputs. Calculators promise precision the underlying data does not support, and they get debunked by the first careful buyer.
  • Lead the homepage with fear. Buyers should opt into risk content after they have read positioning, not get hit with worst-case framing on first paint.

What we will do

Treat the buyer like a peer. If you are a CTO, a compliance lead, or a founder reading this at 11 pm because surveillance is coming or a Series B data room is open, you already know the risk exists. What you need is the shape of it. Which list will my company end up on if we fail? Where is that list published? What does the public record actually show? That is what the Cost of non-compliance page answers.

What this blog is for

Commentary, reviews, real numbers from public enforcement, and field notes from sixteen years of clinical safety and defect prevention work. Some posts will be technical (the engineering bar for a CMS-9115-F Patient Access API, what a real DSI transparency check looks like). Some will be strategic (what an audit committee actually asks, what a Series B technical diligence pack should contain). Some will be opinion (why patient data ownership is not a regulatory checkbox).

Cross-posted to LinkedIn. Reach out if a topic should be on the list.